Resistant Hypertension Now Starts At 13080 Mm Hg | Latest News RSS feed

Resistant Hypertension Now Starts At 13080 Mm Hg - Latest News


Single pill with two drugs could transform blood pressure treatment

It is now ... below 120 mmHg should not be the target for any patient since the risk of harm outweighs the potential benefits. When blood pressure is not controlled by three drugs given in a single pi... read more

Actelion provides an update on the progress towards launching Idorsia - Key results for pipeline assets to be developed by Idorsia

The company will now discuss with health authorities the design of a Phase 3 program which will consist of two studies evaluating the effect of ACT-132577 on systolic and diastolic blood pressure in p... read more

Spotlight on… hypertension

We know that already within the normotensive range that is within normal blood pressure, risk increases with progressive elevation of blood pressure, and that its risk starts to rise at about 115 mm H... read more

Looking for another news?


Medtronic's CEO Discusses F2Q 2014 Results - Earnings Call Transcript

With that, I am now pleased to turn the call over to Medtronic ... which is focused on expanding the indication to include uncontrolled hypertension patients with a systolic pressure between 140 and 1... read more


Bayer to Showcase Latest Oncology Research at ESMO 2018 Congress

In 2011, Bayer entered into an agreement with Onyx, now an Amgen subsidiary ... depending on the severity and persistence of hyperglycemia. Hypertension: Grade 3 hypertension (systolic 160 mmHg or gre... read more

Primary Aldosteronism and Cardiometabolic Risk: Approach to Medical Management

Hypertension ... 137/86 mm Hg and his K is 3.7 mmol/L. You would make which of the following medication changes? A 75-year-old man with longstanding PA who has been treated with MR blockade for severa... read more

Actelion provides an update on the progress towards launching Idorsia – Key results for pipeline assets to be developed by Idorsia

The company will now discuss with health authorities the design of a Phase 3 program which will consist of two studies evaluating the effect of ACT-132577 on systolic and diastolic blood pressure in p... read more

Two drugs in one pill to transform blood pressure treatment

Blood pressure below 120 mmHg should not be the target for any patient since the risk of harm outweighs the potential benefits. When blood pressure is not controlled by three drugs given in a single p... read more

Your Daily Pharma Scoop: AcelRx DSUVIA PDUFA, Ardelyx Phase 3 Success, Rhopressa, LUXTURNA Adcomm Tomorrow

So ACRX gets a running start ... hypertension. Analysis: Per the FDA briefing doc, the drug is more efficacious in a certain subgroup of patients compared to timolol used as control. However, in those ... read more

Medtronic's CEO Discusses F2Q 2014 Results - Earnings Call Transcript

Medtronic (MDT) F2Q 2014 Results Earnings Conference Call November ... on expanding the indication to include uncontrolled hypertension patients with a systolic pressure between 140 and 160 mmHg. We e... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us